annexure b – directors' remuneration
for the year ended 30 June
Directors’ remuneration
The remuneration paid to executive directors while in office of the Company during the year ended 30 June 2018 is analysed as follows:
Director | Basic remuneration R’000 |
Retirement/ medical benefits R’000 |
Other benefits and costs R’000 |
Cash incentives R’000 |
Benefit arising from the exercise of replacement rights R’000 |
Total emoluments R’000 |
|
AW Dawe | 4 843 | 257 | 82 | 7 010 | – | 12 192 | |
---|---|---|---|---|---|---|---|
NT Madisa | 3 301 | 297 | 244 | 4 948 | 13 273 | 22 063 | |
GC McMahon | 1 851 | 240 | 182 | 3 024 | – | 5 297 | |
HP Meijer¹ | 2 336 | 286 | 271 | – | 10 510 | 13 403 | |
LP Ralphs | 10 260 | 880 | 1 011 | 17 492 | – | 29 643 | |
MJ Steyn² | 2 738 | 254 | 102 | 2 500 | 1 782 | 7 375 | |
2018 Total | 25 329 | 2 214 | 1 891 | 34 974 | 25 565 | 89 973 | |
Certain executive directors serve as non-executive directors of companies outside of the Group. Directors’ fees in this regard are paid to the Group.
For comparative purposes the remuneration paid to executive directors, while in office of the Company during the year ended 30 June 2017, is analysed as follows:
Director | Basic remuneration R’000 |
Retirement/ medical benefits R’000 |
Other benefits and costs R’000 |
Cash incentives R’000 |
Benefit arising from the exercise of replacement rights R’000 |
Total emoluments R’000 |
|
AW Dawe | 4 487 | 263 | 76 | 3 347 | – | 8 173 | |
NT Madisa | 3 027 | 272 | 89 | 2 324 | – | 5 712 | |
GC McMahon | 1 672 | 218 | 154 | 1 409 | 4 005 | 7 458 | |
HP Meijer¹ | 3 237 | 397 | 164 | 2 606 | 10 934 | 17 338 | |
LP Ralphs | 9 164 | 825 | 912 | 7 227 | 91 865 | 109 993 | |
2017 Total | 21 587 | 1 975 | 1 395 | 16 913 | 106 804 | 148 674 |
1 Retired 28 February 2018
2 Appointed as Group CFO 1 March 2018. Remuneration for 12 months
The remuneration paid to non-executive directors while in office of the Company during the year ended 30 June 2018 is analysed as follows:
Director | Directors’ fees R’000 |
2018 As directors of subsidiary companies and other services R’000 |
Total emoluments R’000 |
2017 Total R’000 |
|||
DDB Band | 718 | – | 718 | 551 | |||
---|---|---|---|---|---|---|---|
EK Diack | 570 | 508 | 1 078 | 1 583 | |||
B Joffe | 23 | – | 23 | 4 203 | |||
AK Maditsi | 613 | – | 613 | 535 | |||
S Masinga | 595 | – | 595 | 582 | |||
RK Mokate | 114 | 597 | 711 | – | |||
CWN Molope | 371 | – | 371 | – | |||
NG Payne | 1 349 | 875 | 2 224 | 2 169 | |||
CWL Phalatse | 1 430 | – | 1 430 | 1 350 | |||
T Slabbert | 655 | – | 655 | 562 | |||
NW Thomson | 148 | – | 148 | – | |||
2018 total | 6 586 | 1 980 | 8 566 | 11 535 | |||
2017 total | 5 887 | 5 648 | 11 535 | – | |||
Prescribed officers
Due to the nature and structure of the Group and the number of executive directors on the board of the Company, the directors have concluded that there are no prescribed officers of the Company.
Directors’ long-term incentives
Details of the directors’ and officers’ outstanding replacement rights are as follows:
Replacement rights at 30 June 2017 |
Replacement rights exercised during the year |
Replacement rights lapsed during the year |
Replacement rights at 30 June 2018 |
||||||||||||
Directors | Number | Average price R |
Number | Market price3 |
Number | Market price3 |
Number | Average price R |
|||||||
AW Dawe | 133 066 | 267,27 | – | – | – | – | 133 066 | 267,27 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NT Madisa | 118 566 | 266,49 | 50 783 | 240,97 | – | – | 67 783 | 285,60 | |||||||
GC McMahon | 61 250 | 271,44 | – | – | – | – | 61 250 | 271,44 | |||||||
P Meijer | 115 566 | 269,29 | 42 783 | 247,16 | 42 017 | 276,31 | 30 766 | 290,49 | |||||||
MJ Steyn | 45 000 | 260,09 | 7 500 | 250,73 | – | – | 37 500 | 261,96 | |||||||
473 448 | 267,42 | 101 066 | 244,32 | 42 017 | 276,31 | 330 365 | 273,36 | ||||||||
Former company secretary | |||||||||||||||
CA Brighton | 20 578 | 262,26 | 6 539 | 257,56 | 14 039 | 264,44 | – | – | |||||||
494 026 | 267,21 | 107 605 | 245,72 | 56 056 | 273,34 | 330 365 | 273,36 | ||||||||
Refer to note 27 of the financial statements for further details.
A share appreciation right (SAR) is a right awarded subject to the appreciation of the Company’s shares.
SARs at 30 June 2017 |
SARs granted during the year |
SARs lapsed during the year |
SARs at 30 June 2018 |
||||||||||||
Directors | Number | Average price R |
Number | Average price R |
Number | Market price3 |
Number | Average price R |
|||||||
MJ Steyn | 40 000 | 146,61 | 40 000 | 158,75 | – | – | 80 000 | 152,68 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Former company secretary | |||||||||||||||
CA Brighton | 14 000 | 146,61 | – | – | 14 000 | 146,61 | – | – | |||||||
54 000 | 146,61 | 40 000 | 158,75 | 14 000 | 146,61 | 80 000 | 152,68 | ||||||||
These SARs are exercisable over the period 1 July 2019 to 31 December 2024. A detailed register of SARs outstanding by tranche is available for inspection at the Company’s register office.
Share-based payment expense
2018 R’000 |
2017 R’000 |
||||
AW Dawe | 4 211 | 3 687 | |||
---|---|---|---|---|---|
NT Madisa | 3 602 | 3 086 | |||
GC McMahon | 2 048 | 1 834 | |||
HP Meijer | 2 854 | 3 710 | |||
LP Ralphs | 8 786 | 3 920 | |||
MJ Steyn | 1 756 | – | |||
23 257 | 16 237 | ||||
Details of directors’ and officers’ outstanding conditional share plan (CSP)
A conditional award is a conditional right to a share, which is awarded subject to performance and vesting conditions.
Director | Balance at 2017 Number |
New awards Number |
Forfeited Number |
Shares awarded Number |
Closing balance 30 June 2018 Number |
|||||||||
AW Dawe | 28 000 | 38 000 | – | – | 66 000 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GC McMahon | 12 000 | 15 000 | – | – | 27 000 | |||||||||
LP Ralphs | 174 280 | 112 000 | – | – | 286 280 | |||||||||
NT Madisa | 20 000 | 30 000 | – | – | 50 000 | |||||||||
HP Meijer | 22 000 | – | – | – | 22 000 | |||||||||
256 280 | 195 000 | – | – | 451 280 | ||||||||||